AIXC

Handel nachbörslich: 2.58 -0.05 -1.90%

Aixcrypto Holdings Inc (AIXC)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Aixcrypto Holdings Inc Stock (AIXC) Company Profile

Aixcrypto Holdings Inc

Technology (778)

(760) 918-9165

2042 CORTE DEL NOGAL, CALIFORNIA

Nächster Verdiensttermin

Neueste SEC-Einreichungen

AIXC's Discussions on Twitter

Vergleichen Sie AIXC mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
AIXC Aixcrypto Holdings Inc	2.63	13.11M	0	0	0	0.00
MSFT Microsoft Corporation	479.93	3.55T	293.81B	104.91B	78.02B	14.06
ORCL Oracle Corp	214.33	592.20B	59.02B	12.63B	-5.88B	4.3198
PLTR Palantir Technologies Inc	177.75	419.68B	3.90B	1.10B	1.79B	0.4275
CRWD Crowdstrike Holdings Inc	512.55	131.54B	4.34B	-298.19M	1.04B	-1.1966
SNPS Synopsys Inc	463.45	88.89B	6.43B	1.15B	1.30B	12.77

Aixcrypto Holdings Inc Aktie (AIXC) Neueste Nachrichten

Finanzdaten der Aixcrypto Holdings Inc-Aktie (AIXC)

Es liegen keine Finanzdaten für Aixcrypto Holdings Inc (AIXC) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Aixcrypto Holdings Inc (AIXC)

Aixcrypto Holdings Inc Stock (AIXC) Company Profile

Vergleichen Sie AIXC mit anderen Aktien

Aixcrypto Holdings Inc Aktie (AIXC) Neueste Nachrichten

An analyst sees good growth prospects for AIxCrypto Holdings Inc (AIXC) - Setenews

AIxCrypto Rebrands and Begins Trading Under New Ticker AIXC, Advancing Its 'Three Driving Forces' Strategy to Become the No. 1 Gateway to AI Web3 and Bridge Between Web2 and Web3 - Reuters

What's Going On With Faraday Future Stock Monday? - Sahm

Faraday Future (NASDAQ: FFAI) FX Super One Parts Reach Long Beach, Enter Pilot Build - Stock Titan

Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FF Completes its “Dual Flywheel, Dual Bridge, and Dual Listed-Company” Structure; First batch of FX Super One Complete Sets of Components to Arrive at Port of Long Beach Next Week - GlobeNewswire Inc.

AIxCrypto Holdings Regains Nasdaq Compliance After Issue - The Globe and Mail

AIxCrypto Holdings Rebrands, Unveils New Strategy - The Globe and Mail

AIxCrypto Holdings, Inc. Rebrands and Launches New Strategy - TradingView

AIxCrypto Rebrands as AIxCrypto Holdings, Inc., Unveils Bold Web3 Strategy - Bitget

QUALIGEN THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) - MarketScreener

Faraday Future Advances Dual-Listed Framework with AIxCrypto Holdings Inc. Name Change and Strategic Initiatives - Quiver Quantitative

Faraday Future Completes Formation of "FFAI+AIXC" Dual-Flywheel, Dual-Bridge, and Dual-Listed Company System; Its Majority Owned Crypto Company Renamed as AIxCrypto (Nasdaq: AIXC) - Nasdaq

Aixcrypto Holdings Inc appoints Jie Sheng as chairman of boardSEC filing - MarketScreener

AIxCrypto rebrands from Qualigen, unveils three-part strategy By Investing.com - Investing.com Nigeria

AIxCrypto rebrands, begins trading under ‘AIXC’ ticker - TipRanks

Qualigen Therapeutics Rebrands to AIxCrypto Holdings - MSN

AIxCrypto Rebrands and Begins Trading Under New Ticker AIXC, Advancing Its "Three Driving Forces" Strategy to Become the No.1 Gateway to AI Web3 and a Bridge Between Web2 and Web3 - The AI Journal

Jia Yueting-backed listed company QLGN has been renamed AIxCrypto and will launch stock tokenization business - Bitget

Qualigen Therapeutics, Inc. will Change its Name to AIxCrypto Holdings, Inc - MarketScreener

"Biotech-to-DeAI Transformation: AIxCrypto Rises as the Portal to the Web3 Age" - Bitget

Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: On November 20, QLGN, which is Strategically Invested in and Controlled by FFAI, will Begin Using its New Name, AIxCrypto, and will be Traded Under AIXC - The Manila Times

Qualigen Therapeutics Stockholders Approve All Proposals with Majority Vote; Company to Rebrand as AIxCrypto Holdings, Inc. Following November 20 Nasdaq Ceremony and Announces Transition into AI × Web3 Strategy - Investing News Network

Faraday Future Becomes Majority Shareholder in Qualigen Therapeutics, Preparing for Corporate Rebranding and Strategic Transformation on November 20 - Quiver Quantitative

Qualigen (NASDAQ: QLGN) to Rebrand as AIxCrypto, Launch AI × Web3 Strategy Nov. 20 - Stock Titan

QLGN to Become AIxCrypto as Faraday Future (NASDAQ: FFAI) Takes Control, AIXC Ticker - Stock Titan

Qualigen Therapeutics Inc. Announces Rebranding to AIxCrypto and Launch of Web3 Initiatives - Quiver Quantitative

Qualigen Therapeutics to Rebrand as AIxCrypto After - GlobeNewswire

Qualigen (NASDAQ: QLGN) chooses BitGo for $30M C10 treasury in top 10 crypto basket - Stock Titan

$16B Liquidated in Crypto Sell-Off — Qualigen Launches C10 Treasury Buying Program Next Week - Stock Titan

Co-CEO Jerry Wang & CFO Koti Meka join Qualigen; Board adds 3 directors and auditor switches to MGO for FY2025 - Stock Titan

$41M Crypto Transformation: Qualigen Partners with EV Giant Faraday Future for Web3 Evolution to CXC10 - Stock Titan

$41M Strategic Investment: EV Maker Faraday Future Pivots to Crypto with Majority Stake in Qualigen - Stock Titan

Qualigen Secures Nasdaq Listing Status with $4.5M Strategic Funding, Addresses All Compliance Issues - Stock Titan

Qualigen's Cancer Treatment Patent Portfolio Expands to 25 Countries, Protection Until 2040 - Stock Titan

Qualigen Therapeutics, Inc. Appoints Robert B. Lim to Serve as Chair of the Audit Committee of the Board - MarketScreener

Nasdaq Threatens to Delist Qualigen on May 5: Company Plans Last-Minute Appeal - Stock Titan

Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN) - MarketScreener

Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares - MarketScreener

Qualigen Therapeutics, Inc. Appoints Graydon Bensler as an Independent Member - MarketScreener

Qualigen Therapeutics : Shares Expected to Begin Trading on Split Adjusted Basis on November 5, 2024 Form 8 K - MarketScreener

Qualigen Therapeutics, Inc. Announces Chief Executive Officer Changes - MarketScreener

Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel - MarketScreener

Univest Securities, LLC Announces Closing of $3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. - MarketScreener

Qualigen Therapeutics to Seek Acquisitions - MarketScreener

Qualigen Therapeutics, Inc. Announces Pricing of $3.46 Million Public Offering - MarketScreener

Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination - MarketScreener

Qualigen Therapeutics Provides Corporate Update for Third Quarter and To Date 2023 - MarketScreener

Qualigen Therapeutics, Inc. Announces First Patient Dosed in the Phase 1a Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors - MarketScreener

Qualigen Therapeutics Announces US FDA IND Clearance to Initiate Phase 1 Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors - MarketScreener

Qualigen Therapeutics, Inc. Announces the Resignation of Amy Broidrick as President, Chief Strategy and Operating Officer and A Director, Effective June 16, 2023 - MarketScreener

QUALIGEN THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K) - MarketScreener

Finanzdaten der Aixcrypto Holdings Inc-Aktie (AIXC)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie AIXC